PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice
PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Several lipid guidelines recommend that proprotein convertase subtilisin/kexin type 9 inhibitors should be considered for patients with atherosclerotic cardiovascular disease who are inadequately treated with maximally tolerated lipid-lowering treatment.
Objectives
The PEARL study assessed the efficacy and safety of the proprote...
Alternative Titles
Full title
PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a4aa85a0d1cb4c558b5d95a0b01ee7b6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a4aa85a0d1cb4c558b5d95a0b01ee7b6
Other Identifiers
ISSN
2199-1154
E-ISSN
2198-9788
DOI
10.1007/s40801-019-0158-0
